Michael A. Sherer

1.2k total citations
18 papers, 908 citations indexed

About

Michael A. Sherer is a scholar working on Cellular and Molecular Neuroscience, Toxicology and Pharmacology. According to data from OpenAlex, Michael A. Sherer has authored 18 papers receiving a total of 908 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Cellular and Molecular Neuroscience, 8 papers in Toxicology and 4 papers in Pharmacology. Recurrent topics in Michael A. Sherer's work include Neurotransmitter Receptor Influence on Behavior (8 papers), Forensic Toxicology and Drug Analysis (7 papers) and Attention Deficit Hyperactivity Disorder (2 papers). Michael A. Sherer is often cited by papers focused on Neurotransmitter Receptor Influence on Behavior (8 papers), Forensic Toxicology and Drug Analysis (7 papers) and Attention Deficit Hyperactivity Disorder (2 papers). Michael A. Sherer collaborates with scholars based in United States, United Kingdom and Czechia. Michael A. Sherer's co-authors include Karen M. Kumor, Jerome H. Jaffe, Nicola G. Cascella, Edward J. Cone, Steven James, David Yousefnejad, Matthew V. Rudorfer, Robert N. Golden, William Z. Potter and David A. Sack and has published in prestigious journals such as American Journal of Psychiatry, Biological Psychiatry and Life Sciences.

In The Last Decade

Michael A. Sherer

17 papers receiving 868 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michael A. Sherer United States	13	591	259	200	155	146	18	908
Gene‐Jack Wang United States	7	723 1.2×	183 0.7×	149 0.7×	128 0.8×	231 1.6×	8	1.0k
Tomoji Yanagita Japan	15	857 1.5×	308 1.2×	87 0.4×	131 0.8×	199 1.4×	50	1.2k
Trent J. Volz United States	17	833 1.4×	441 1.7×	151 0.8×	128 0.8×	140 1.0×	21	1.2k
Lisa R. Gerak United States	20	832 1.4×	296 1.1×	144 0.7×	245 1.6×	172 1.2×	87	1.1k
J D Sapira United States	7	459 0.8×	117 0.5×	118 0.6×	242 1.6×	179 1.2×	14	986
Kunio Yui Japan	18	427 0.7×	263 1.0×	108 0.5×	177 1.1×	215 1.5×	71	1.1k
Patrik Munzar United States	20	880 1.5×	402 1.6×	127 0.6×	455 2.9×	96 0.7×	27	1.3k
Fernando Boix Norway	24	868 1.5×	423 1.6×	109 0.5×	151 1.0×	285 2.0×	53	1.5k
Brett C. Ginsburg United States	16	485 0.8×	187 0.7×	150 0.8×	257 1.7×	109 0.7×	62	797
Robert M. Virus United States	12	632 1.1×	208 0.8×	251 1.3×	164 1.1×	301 2.1×	18	1.1k

Countries citing papers authored by Michael A. Sherer

Since Specialization

Citations

This map shows the geographic impact of Michael A. Sherer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael A. Sherer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael A. Sherer more than expected).

Fields of papers citing papers by Michael A. Sherer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael A. Sherer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael A. Sherer. The network helps show where Michael A. Sherer may publish in the future.

Co-authorship network of co-authors of Michael A. Sherer

This figure shows the co-authorship network connecting the top 25 collaborators of Michael A. Sherer. A scholar is included among the top collaborators of Michael A. Sherer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael A. Sherer. Michael A. Sherer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Gregori, Maria, Mark Taylor, Elisa Salvati, et al.. (2016). Retro-inverso peptide inhibitor nanoparticles as potent inhibitors of aggregation of the Alzheimer's Aβ peptide. Nanomedicine Nanotechnology Biology and Medicine. 13(2). 723–732. 46 indexed citations

Sherer, Michael A., Nigel J. Fullwood, Mark P. Taylor, & David Allsop. (2015). A preliminary electron microscopic investigation into the interaction between Aβ_1-42peptide and a novel nanoliposome- coupled retro-inverso peptide inhibitor, developed as a potential treatment for Alzheimer's disease. Journal of Physics Conference Series. 644. 12040–12040. 4 indexed citations

Sherer, Michael A., et al.. (2008). A Case of Obsessiveness Induced by Levetiracetam in a Patient with Epilepsy, Intellectual Disability and Pervasive Developmental Disorder. 11(1). 22. 4 indexed citations

Rudorfer, Matthew V., et al.. (1991). Acute Noradrenergic Effects of Desipramine in Depression. Journal of Clinical Psychopharmacology. 11(1). 22???27–22???27. 5 indexed citations

Kumor, Karen M., et al.. (1989). Subjective response during continuous infusion of cocaine. Pharmacology Biochemistry and Behavior. 33(2). 443–452. 30 indexed citations

Sherer, Michael A., Karen M. Kumor, & Jerome H. Jaffe. (1989). Effects of intravenous cocaine are partially attenuated by haloperidol. Psychiatry Research. 27(2). 117–125. 84 indexed citations

Kumor, Karen M., Michael A. Sherer, & Jerome H. Jaffe. (1989). Effects of bromocriptine pretreatment on subjective and physiological responses to IV cocaine. Pharmacology Biochemistry and Behavior. 33(4). 829–837. 33 indexed citations

Jaffe, Jerome H., Nicola G. Cascella, Karen M. Kumor, & Michael A. Sherer. (1989). Cocaine-induced cocaine craving. Psychopharmacology. 97(1). 59–64. 324 indexed citations

Cascella, Nicola G., Carles Muntaner, Karen M. Kumor, et al.. (1989). Cardiovascular responses to cocaine placebo in humans: A preliminary report. Biological Psychiatry. 25(3). 285–295. 16 indexed citations

10.

Kumor, Karen M., et al.. (1988). Lack of cardiovascular tolerance during intravenous cocaine infusions in human volunteers. Life Sciences. 42(21). 2063–2071. 28 indexed citations

11.

Cone, Edward J., et al.. (1988). Correlation of Saliva Cocaine Levels with Plasma Levels and with Pharmacologic Effects after Intravenous Cocaine Administration in Human Subjects. Journal of Analytical Toxicology. 12(4). 200–206. 74 indexed citations

12.

Sherer, Michael A.. (1988). Intravenous cocaine: Psychiatric effects, biological mechanisms. Biological Psychiatry. 24(8). 865–885. 62 indexed citations

13.

Sherer, Michael A.. (1988). Suspiciousness Induced by Four-Hour Intravenous Infusions of Cocaine. Archives of General Psychiatry. 45(7). 673–673. 58 indexed citations

14.

Yousefnejad, David, et al.. (1987). Confirmation of Cocaine in Human Saliva After Intravenous Use. Journal of Analytical Toxicology. 11(1). 36–38. 60 indexed citations

15.

Sherer, Michael A., Giulio L. Cantoni, Robert N. Golden, Matthew V. Rudorfer, & William Z. Potter. (1986). Effects of S-adenosyl-methionine on plasma norepinephrine, blood pressure, and heart rate in healthy volunteers. Psychiatry Research. 17(2). 111–118. 10 indexed citations

16.

Golden, Robert N., Steven James, Michael A. Sherer, et al.. (1985). Psychoses associated with bupropion treatment. American Journal of Psychiatry. 142(12). 1459–1462. 53 indexed citations

17.

Sherer, Michael A., Herbert Weingartner, Steven James, & Norman E. Rosenthal. (1985). Effects of melatonin on performance testing in patients with seasonal affective disorder. Neuroscience Letters. 58(3). 277–282. 16 indexed citations

18.

Sherer, Michael A.. (1965). Naphthalene-induced hemolytic anemia in a child with erythrocyte glucose-6-phosphate dehydrogenase deficiency.. PubMed. 65(1). 60–7. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact